Mon, 15 Jul 2019 04:29:09 GMT
Gilead raises its stake in Galapagos with $5.1B deal
Gilead Sciences is deepening its ties with Galapagos NV by investing $5.1B to increase its stake in the Belgian-Dutch biotech company, as it seeks for a ten-year partnership to develop and commercialise its treatments.